Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT05995028
What this trial is testing

Universal 4SCAR7U Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Not applicableEnded earlyNCT03080792
What this trial is testing

Pre-Exercise for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Cancer, Hematological
University Hospital Heidelberg 14
Early research (Phase 1)Ended earlyNCT03588936
What this trial is testing

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Who this might be right for
Acute LeukemiaChronic LeukemiaLymphoma+1 more
Medical College of Wisconsin 2
Not applicableLooking for participantsNCT05306509
What this trial is testing

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology

Who this might be right for
Solid TumorHematological Malignancies
Children's Hospital of Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT00843947
What this trial is testing

Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan

Who this might be right for
Hematologic Malignancies
University of California, Davis 8
Testing effectiveness (Phase 2)Study completedNCT00241358
What this trial is testing

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more
Washington University School of Medicine 92
Not applicableLooking for participantsNCT07445984
What this trial is testing

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Who this might be right for
Chronic LeukemiaAcute LeukemiaMyeloproliferative Disorders+2 more
Azienda Ospedaliero-Universitaria di Parma 250
Not applicableStudy completedNCT05053100
What this trial is testing

Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study

Who this might be right for
Acute LeukemiaDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+5 more
Mayo Clinic 100
Early research (Phase 1)Looking for participantsNCT04077307
What this trial is testing

A Study in Leukemia Patients With Karonudib

Who this might be right for
Leukemia
Thomas Helleday Foundation 50
Early research (Phase 1)UnknownNCT06049667
What this trial is testing

Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Nanjing Chia-tai Tianqing Pharmaceutical 72
Not applicableLooking for participantsNCT07357038
What this trial is testing

A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis

Who this might be right for
Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China 38
Early research (Phase 1)Not Yet RecruitingNCT07110194
What this trial is testing

Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies

Who this might be right for
CD20-positive Hematological Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 75
Not applicableUnknownNCT02828462
What this trial is testing

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

Who this might be right for
Metastatic CancerHematological Malignancy
Gustave Roussy, Cancer Campus, Grand Paris 1,000
Early research (Phase 1)Not Yet RecruitingNCT06647329
What this trial is testing

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Who this might be right for
CAR-T Cell TherapyLymphomas
Mingzhi Zhang 30
Not applicableStudy completedNCT03349931
What this trial is testing

Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis in Patients With Onco-haematological Diseases
Assistance Publique - Hôpitaux de Paris 350
Testing effectiveness (Phase 2)UnknownNCT03654703
What this trial is testing

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 100
Early research (Phase 1)Ended earlyNCT03465540
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more
Amgen 24
Not applicableLooking for participantsNCT07445438
What this trial is testing

Feasibility of a Multi-omics Platform for Hematological Malignancies

Who this might be right for
Myeloma MultipleChronic LeukemiaAcute Leukemia+3 more
Azienda Ospedaliero-Universitaria di Parma 1,040
Not applicableLooking for participantsNCT01821456
What this trial is testing

Cologne Cohort of Neutropenic Patients (CoCoNut)

Who this might be right for
Hematological MalignanciesCancerChemotherapy+2 more
University Hospital of Cologne 100,000
Testing effectiveness (Phase 2)UnknownNCT02794961
What this trial is testing

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

Who this might be right for
Recurrent or Refractory B Cell Malignancy
Kai Lin Xu; Jun Nian Zheng 10
Next Page